Focus on knowledge creation
Without ideas there is nothing to manage
The iPiE Summary Database Search (iPiE*Sum) is launched
The overall aim of iPiE is to is to develop frameworks that utilize information from toxicological studies, pharmacological mode of action and in silico models to support more intelligent environmental testing of pharmaceuticals in development and to prioritise legacy...
RESCEU presented at the EMA Vaccine Working Party Meeting
RESCEU Work Package 2 representatives met with the EMA Vaccine Working Party (VWP) on June 7th at the EMA in London, as part of the RESCEU efforts for establishing continuous communication and collaboration with Regulatory Bodies. RESCEU representatives and EMA VWP...
AMYPAD diagnostic and patient management study enrols its first research participant
The members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) initiative proudly announced the recruitment of its first research participant today. The first participant was recruited in Geneva, Switzerland, within the diagnostic and patient management...
A Methodological Proposal from the ADVANCE Project published in Drug Safety journal
The ADVANCE project aspires to develop a blueprint for a framework capable of rapidly delivering reliable data on the benefits and risks of vaccines. Data on vaccine-preventable diseases and adverse reactions to vaccines exist in many places in diverse formats of...
The ROADMAP consortium publishes its second article – a systematic review protocol
The ROADMAP project provides the foundation for an integrated data environment and framework for real-world evidence in Alzheimer’s disease. This includes the development of consensual key outcome measures and enabling data integration tools for...
The University of Oxford, a TransQST consortium partner, won the 2017 NC3Rs Prize
The UK-based National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) awarded its 2017 International prize to the team of Computer of Science Department (University of Oxford), for their research which developed original in silico...
• University degree in Advertising and Public Relationships, Universitat Autònoma de Barcelona.
• University degree in Industrial Engineering, Universidad Tecnológica Nacional.
• Master in Corporate Communication, Protocol and Events, Universitat Oberta de Catalunya.
• BSc in Biology by the University of Barcelona, complemented by a Master degree in “Basic fundamentals of oncogenesis” by the University of Paris VI and Master in Business and Administration by the ESG (Paris).
• Ph.D. Medical Informatics.
• University degree in Political and Administration Sciences, Universitat Pompeu Fabra.
• Bachelor’s Degree in Communication from Instituto Tecnológico y de Estudios Superiores de Monterrey and in Journalism from Universidad Nacional Autónoma de México.
• University degree in Political Science and International Relations, Universidad Nacional de Rosario.
• PhD in Psychology, University of Edinburgh.
• University degree in Nursing, Universitat Autònoma de Barcelona.
• University double degree in Law & Political Sciences, Universidad Autónoma de Madrid.
• University degree in Telecommunication Engineering, Universidad Politécnica de Madrid.
• University degree in Business Administration, University of Barcelona.
• Ph.D. in Molecular Toxicology, University of Colorado Boulder.
• B.A. in Economics with Honors and Distinction from Stanford University.
• University degree in Tourism, Universitat de Barcelona.
• Ph.D. in Psychology and Neuroscience, Universidad Complutense de Madrid.
• University degree in Psychology, Universitat Autònoma de Barcelona.
• University degree in Social Sciences, Universidad de Vigo.
• University degree in Economy and Business Administration (Extraordinary Award), Universitat Autònoma de Barcelona.